A new trading day began on Tuesday, with Dermata Therapeutics Inc (NASDAQ: DRMA) stock price up 22.58% from the previous day of trading, before settling in for the closing price of $1.86. DRMA’s price has ranged from $1.58 to $23.70 over the past 52 weeks.
During the last 5-year period, the sales growth of Healthcare Sector giant was 43.22%. Meanwhile, its annual earnings per share averaged 90.04%. With a float of $0.75 million, this company’s outstanding shares have now reached $0.84 million.
Dermata Therapeutics Inc (DRMA) Breakdown of a Key Holders of the stock
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of Dermata Therapeutics Inc is 26.85%, while institutional ownership is 8.99%.
Dermata Therapeutics Inc (DRMA) Recent Fiscal highlights
In its latest quarterly report, released on 12/31/2024, the company reported earnings of -13.4 per share, which was $0.1 higher than the consensus estimate of $0.26. In terms of return on equity, this company recorded -19.55% in contrast with 50.0% return on Investment (trailing twelve months). Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.72 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 90.04% per share during the next fiscal year.
Dermata Therapeutics Inc (NASDAQ: DRMA) Trading Performance Indicators
Here are Dermata Therapeutics Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 4.56.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -20.29, a number that is poised to hit -1.54 in the next quarter and is forecasted to reach -3.01 in one year’s time.
Technical Analysis of Dermata Therapeutics Inc (DRMA)
Looking closely at Dermata Therapeutics Inc (NASDAQ: DRMA), its last 5-days average volume was 9.43 million, which is a jump from its year-to-date volume of 0.29 million. As of the previous 9 days, the stock’s Stochastic %D was 31.63%.
During the past 100 days, Dermata Therapeutics Inc’s (DRMA) raw stochastic average was set at 13.74%, which indicates a significant decrease from 50.00% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.2800 in the past 14 days, which was lower than the 0.3500 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $2.9600, while its 200-day Moving Average is $6.0400. However, in the short run, Dermata Therapeutics Inc’s stock first resistance to watch stands at $2.5100. Second resistance stands at $2.7300. The third major resistance level sits at $2.8900. If the price goes on to break the first support level at $2.1300, it is likely to go to the next support level at $1.9700. Now, if the price goes above the second support level, the third support stands at $1.7500.
Dermata Therapeutics Inc (NASDAQ: DRMA) Key Stats
With a market capitalization of 2.34 million, the company has a total of 1,026K Shares Outstanding. Currently, annual sales are 0 K while annual income is -12,290 K. The company’s previous quarter sales were 0 K while its latest quarter income was -1,690 K.
